10 Billion Won Spent to Expand Hpv Vaccine Coverage to Men, yet the Debate Rises over ‘9-Variable’ Globally vs. ‘4-Variable’ in Korea

조선일보

Lean Right

Factuality

Ownership

"We spent 10 billion won to expand HPV vaccination to men, yet the debate rages over whether the world uses the 9-valent or Korea uses the 4-valent. Experts say men have lower HPV antibody formation rates and that 80% of both sexes must be vaccinated to eradicate the virus. 29 OECD countries support Gardasil 9 for both men and women, while Korea remains stuck with the 4-valent; switching would require up to 16.5 billion won in additional budget."